Save time and get answers to complex questions with AI chat
Prolia and osteonecrosis?Is guselkumab off patent in u s?Mobic injection patent oehringer ingelheim france?Bortezomib market france?Is januvia still on the market?
See the DrugPatentWatch profile for Kisqali
Kisqali is ribociclib. It’s a small-molecule CDK4/CDK6 inhibitor used in HR+/HER2- breast cancer. If you’d like the exact structure in a specific format, I can provide any of the following: - 2D structure image (link to PubChem/Wikipedia) - SMILES string - InChI/InChIKey - IUPAC name Which format would you prefer? If you want, I can fetch the precise SMILES/InChI or a direct image link for ribociclib.
Other Questions About Kisqali :